Frank Passero

546 total citations
25 papers, 411 citations indexed

About

Frank Passero is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Frank Passero has authored 25 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Frank Passero's work include Pancreatic and Hepatic Oncology Research (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Cancer Genomics and Diagnostics (3 papers). Frank Passero is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Cancer Genomics and Diagnostics (3 papers). Frank Passero collaborates with scholars based in United States, Greece and France. Frank Passero's co-authors include Muhammad Wasif Saif, Kostas Syrigos, Dimitra Grapsa, Dashnamoorthy Ravi, William B. Young, Andrew M. Evens, Michael J. Marmura, Afshin Beheshti, E. Bryan Crenshaw and Kyung Jin Ahn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Frank Passero

24 papers receiving 393 citations

Peers

Countries citing papers authored by Frank Passero

Since Specialization

Citations

This map shows the geographic impact of Frank Passero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Passero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Passero more than expected).

Fields of papers citing papers by Frank Passero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Passero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Passero. The network helps show where Frank Passero may publish in the future.

Co-authorship network of co-authors of Frank Passero

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Passero. A scholar is included among the top collaborators of Frank Passero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Passero. Frank Passero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Rare Case of Renal Thrombotic Microangiopathy and Focal Segmental Glomerulosclerosis Secondary to Plasma Cell Leukemia 2023 ·SHILAP Revista de lepidopterología ·Justin Komisarof, (unknown), Bruce Goldman, (unknown), Frank Passero, (unknown)	1
2	Denosumab for smoldering multiple myeloma: Rates of osteoporosis and change in lowest T-score after 12 months of treatment. 2023 ·Journal of Clinical Oncology ·(unknown), Andrea Baran, Frank Passero, (unknown), Brea Lipe	0
3	Denosumab for the Treatment of Smoldering Multiple Myeloma: Rates of Osteoporosis and Change in Lowest T-Score after 12 Months of Treatment 2022 ·Blood ·(unknown), Andrea Baran, Frank Passero, (unknown), Brea Lipe	1
4	Oncogenic Integration of Nucleotide Metabolism via Fatty Acid Synthase in Non-Hodgkin Lymphoma 2021 ·Frontiers in Oncology ·Dashnamoorthy Ravi, Afshin Beheshti, Nasséra Abermil, Frederick Lansigan, William B. Kinlaw, Nirupa R. Matthan, (unknown), Frank Passero, (unknown), Kevin A. David, Gregory G. Dolnikowski, Xiaoyang Su, Ying Chen, (unknown), Rohan Varshney, Baek Kim, Sandeep S. Davé, Michael C. Rudolph, Andrew M. Evens	11
5	A review of thrombotic microangiopathies in multiple myeloma 2019 ·Leukemia Research ·Andrew J. Portuguese, (unknown), Frank Passero, Brea Lipe	18
6	Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphoma 2019 ·Leukemia ·Dashnamoorthy Ravi, Saheli Sarkar, Sneha Purvey, Frank Passero, Afshin Beheshti, Ying Chen, (unknown), Kevin A. David, Tania Konry, Andrew M. Evens	32
7	Ostomy telehealth for cancer survivors: Design of the Ostomy Self-management Training (OSMT) randomized trial 2017 ·Contemporary Clinical Trials ·Virginia Sun, Elizabeth Ercolano, Ruth McCorkle, Marcia Grant, Christopher S. Wendel, (unknown), Frank Passero, (unknown), Zuleyha Cidav, Michael J. Holcomb, Ronald S. Weinstein, Mark C. Hornbrook, Robert S. Krouse	48
8	Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma 2016 ·Cancer Research ·Dashnamoorthy Ravi, Afshin Beheshti, Nasséra Abermil, Frank Passero, (unknown), (unknown), Athena Kritharis, Irawati Kandela, Lynn Hlatky, Michail V. Sitkovsky, Andrew P. Mazar, Ronald B. Gartenhaus, Andrew M. Evens	34
9	The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy 2016 ·Expert Review of Anticancer Therapy ·Frank Passero, Dimitra Grapsa, Kostas Syrigos, Muhammad Wasif Saif	112
10	CD19 Target Activated Natural Killer (CD19.TaNK) Cellular Therapy: A Novel immunotherapeutic Approach to the Treatment of Non-Hodgkin Lymphoma (NHL) 2016 ·Blood ·Dashnamoorthy Ravi, Afshin Beheshti, Saheli Sarkar, Pooja Sabhachandani, Frank Passero, Sneha Purvey, Laurent Boissel, Tania Konry, Andrew M. Evens	1
11	The Proteasome Inhibitor, Ixazomib, Combined with Novel Drug Combinations in T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL): Identification of Key Genes and Signaling Pathways Via a Novel Systems Biology Approach 2015 ·Blood ·Frank Passero, Dashnamoorthy Ravi, Afshin Beheshti, Lynn Hlatky, Nasséra Abermil, (unknown), (unknown), Andrew M. Evens	2
12	Recent advances in pancreatic cancer: updates and insights from the 2015 annual meeting of the American Society of Clinical Oncology 2015 ·Therapeutic Advances in Gastroenterology ·Matthew J. Abrams, Kevin Rakszawski, Monali Vasekar, Frank Passero, (unknown), Yuxia Jia, Muhammad Wasif Saif	9
13	Retrospective Analysis of Heparin-Induced Thrombocytopenia Management at a Large Tertiary Hospital 2014 ·Frank Passero, (unknown)	3
14	Otic mesenchyme expression of Cre recombinase directed by the inner ear enhancer of the Brn4/Pou3f4 gene 2009 ·genesis ·Kyung Jin Ahn, Frank Passero, E. Bryan Crenshaw	19
15	Mexiletine for Refractory Chronic Daily Headache: A Report of Nine Cases 2008 ·Headache The Journal of Head and Face Pain ·Michael J. Marmura, Frank Passero, William B. Young	26
16	Lumbar Petriellidium boydii Osteomyelitis with a Systemic Presentation 1994 ·Journal of Spinal Disorders ·(unknown), Zachary B. Friedenberg, Frank Passero	10
17	SERUM AMYLASE AND MACROAMYLASE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS 1988 ·Lara D. Veeken ·Peter Hasselbacher, Allen R. Myers, Frank Passero	9
18	Scleritis, Pericarditis, and Aortic Insufficiency in a Patient with Rheumatoid Arthritis 1984 ·Ophthalmology ·Robert C. Kleiner, Irving M. Raber, Frank Passero	9
19	Factor xii deficiency with systemic lupus erythematosus 1979 ·Arthritis & Rheumatism ·Frank Passero, Allen R. Myers, DuPont Guerry	2
20	Topography of Nucleic Acid Helices in Solutions. Stoichiometry and Specificity of the Interaction of Reporter Molecules with Nucleic Acid Helices 1970 ·Macromolecules ·Frank Passero, Edmond J. Gabbay, (unknown), (unknown)	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact